Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and Lewis antigen in mucinous cystadenocarcinoma
- PMID: 1728413
Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and Lewis antigen in mucinous cystadenocarcinoma
Abstract
Among several human ovarian tumors, which include mucinous cystadenocarcinoma, serous cystadenocarcinoma, and clear cell adenocarcinoma, the mucinous cystadenocarcinoma showed a unique glycosphingolipid composition. In particular, more than 90% of the acidic glycosphingolipids in the mucinous cystadenocarcinoma is comprised of sulfolipids, which are hardly detected in normal ovary and are contained in concentrations of less than 40% in the other type of ovarian tumors. By means of negative ion fast atom bombardment mass spectrometry and gas liquid chromatography, the major sulfolipid in mucinous cystadenocarcinoma is confirmed to be I3SO3-GalCer with N-cerebronoyl phytosphingosine, that which contrasts with I3SO3-GalCer with N-nonhydroxy fatty acyl sphingosine as the major molecular species in the other ovarian cancers. In mucinous cystadenocarcinoma, galactosylceramide is found in the relatively high concentration and is also composed of N-cerebronoyl phytosphingosine. In addition, the concentrations of glycolipids with Le(a) and Le(b) antigenicities are significantly higher in mucinous cystadenocarcinoma than those in normal ovary and the other ovarian tumors.
Similar articles
-
Human uterine endometrial adenocarcinoma: characteristic acquirement of synthetic potentials for II3SO3-LacCer and ganglio series sulfoglycosphingolipids after transfer of the cancer cells to culture.Cancer Res. 1992 Feb 15;52(4):803-9. Cancer Res. 1992. PMID: 1737340
-
Fucosylated glycosphingolipids of human myeloid cells.Arch Biochem Biophys. 1993 Feb 1;300(2):677-83. doi: 10.1006/abbi.1993.1094. Arch Biochem Biophys. 1993. PMID: 8434948
-
Argyrophilia in ovarian serous tumors. A comparative study in 127 epithelial ovarian tumors.Histol Histopathol. 1991 Oct;6(4):477-84. Histol Histopathol. 1991. PMID: 1804424
-
Serum and tissue measurements of CA72-4 in ovarian cancer patients.Gynecol Oncol. 1993 Feb;48(2):148-54. doi: 10.1006/gyno.1993.1026. Gynecol Oncol. 1993. PMID: 8381375
-
Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.Cancer Res. 1988 Aug 15;48(16):4639-45. Cancer Res. 1988. PMID: 2456145
Cited by
-
Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas.Oncol Lett. 2010 Nov;1(6):1061-1066. doi: 10.3892/ol.2010.171. Epub 2010 Sep 9. Oncol Lett. 2010. PMID: 22870113 Free PMC article.
-
Enhanced expression of hydroxylated ceramide in well-differentiated endometrial adenocarcinoma.Oncol Lett. 2017 Jan;13(1):45-50. doi: 10.3892/ol.2016.5410. Epub 2016 Nov 22. Oncol Lett. 2017. PMID: 28123520 Free PMC article.
-
Expression of sulfatide and sulfated lactosylceramide among histological types of human ovarian carcinomas.Hum Cell. 2015 Jan;28(1):37-43. doi: 10.1007/s13577-014-0100-4. Epub 2014 Sep 12. Hum Cell. 2015. PMID: 25212460
-
Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.Mol Cancer. 2010 Jul 12;9:186. doi: 10.1186/1476-4598-9-186. Mol Cancer. 2010. PMID: 20624317 Free PMC article.
-
A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences.J Lipid Res. 2011 Jun;52(6):1073-1083. doi: 10.1194/jlr.M010454. Epub 2011 Mar 17. J Lipid Res. 2011. PMID: 21415121 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical